Stuart A. Arbuckle, EVP, COO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 14,782 shares at $425.70 ($6.3M) on 2024-02-26, disclosed to the SEC on 2024-02-27.
Scheduled sale ($6.3M) by EVP, COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $431.79 | 4,714 | $2.0M | 32.2% |
| 2 | $425.70 | 5,034 | $2.1M | 33.9% |
| 3 | $425.70 | 5,034 | $2.1M | 33.9% |
| Total | $427.64 avg | 14,782 | $6.3M | 100% |
| Filing → |
| VRTX | SELL | 2024-02-21 | $4.0M | — | Filing → |
| VRTX | SELL | 2024-02-13 | $3.6M | — | Filing → |
| VRTX | SELL | 2023-12-15 | $3.4M | — | Filing → |